Back to ACAD
Signature Equity Partners, LLC → ACAD
Signature Equity Partners, LLC ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
8
Latest value
$1M
Q3 2026
Peak value
$1M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $52K |
| Q4 2025 | $835K |
| Q1 2026 | $42K |
| Q1 2026 | $847K |
| Q2 2026 | $45K |
| Q2 2026 | $924K |
| Q3 2026 | $36K |
| Q3 2026 | $1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1M | 5.7K | — | — |
| Q3 2026 | $36K | 1.8K | — | — |
| Q2 2026 | $924K | 5.3K | — | — |
| Q2 2026 | $45K | 1.8K | — | — |
| Q1 2026 | $847K | 5.2K | — | — |
| Q1 2026 | $42K | 1.9K | — | — |
| Q4 2025 | $835K | 4.7K | — | — |
| Q4 2025 | $52K | 2.0K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M